Anti-TNF therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells

先天免疫系统 肿瘤坏死因子α 免疫学 免疫系统 生物 受体 炎症 遗传学
作者
Shuyi Wang,Ruoxi Xiao,Yibo Chen,Yishan Ye,Tianzhen He,Yang Yang,Xin Chen,Chon‐Kit Chou
出处
期刊:Journal of Leukocyte Biology [Oxford University Press]
标识
DOI:10.1093/jleuko/qiaf026
摘要

Abstract Systemic autoinflammatory diseases (SAIDs) are rare conditions resulting from innate immune system dysregulation, culminating in repetitive bouts of systemic inflammation without the presence of external or self-antigens. Most SAIDs are associated with mutations in genes affecting the innate immune response. Tumor necrosis factor (TNF) is a central player in the pathogenesis of numerous chronic inflammatory disorders, and anti-TNF therapy is widely used in the clinical management of SAIDs. TNF inhibitors block the interaction of TNF with its two receptors, TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2). These inhibitors primarily target soluble TNF (sTNF), which mainly binds to TNFR1, exerting anti-inflammatory effects. Interestingly, TNF inhibitors also affect transmembrane TNF (tmTNF), which engages TNFR2 to initiate reverse signaling. This reverse signaling can activate innate immune cells, prevent apoptosis, or paradoxically inhibit the production of pro-inflammatory cytokines. TNF inhibitors also promote the release of soluble TNFR2 (sTNFR2), which neutralizes circulating TNF. Some agents targeting TNFR2 can even act as agonists, triggering reverse signaling by binding to tmTNF. While effective, prolonged use of TNF inhibitors may cause significant side effects due to the widespread expression and pleiotropic functions of TNF receptors. More thoroughly understanding of the mechanisms underlying the action of TNF inhibitors is required to develop more effective and safer treatment for SAIDs. This article reviews current studies on the role of the innate immune system in SAID pathogenesis, the impact of anti-TNF therapy on innate immune cells, and perspectives on developing improved agents targeting TNF or its receptors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kilig完成签到 ,获得积分10
1秒前
顾矜应助烊烊采纳,获得10
1秒前
平平无奇打工人完成签到 ,获得积分10
4秒前
Young完成签到 ,获得积分10
5秒前
陳某完成签到,获得积分10
6秒前
赖道之发布了新的文献求助10
7秒前
一区的王完成签到 ,获得积分10
8秒前
搬砖的化学男完成签到 ,获得积分0
9秒前
满意的迎南完成签到 ,获得积分10
9秒前
wang完成签到,获得积分10
9秒前
Lynn完成签到 ,获得积分10
15秒前
踏实的无敌完成签到,获得积分10
17秒前
18秒前
星辰大海应助淡然的熊猫采纳,获得10
25秒前
piaoaxi完成签到 ,获得积分10
26秒前
mol完成签到 ,获得积分10
26秒前
27秒前
烊烊完成签到,获得积分10
30秒前
yang杨完成签到,获得积分10
30秒前
thuuu完成签到,获得积分10
32秒前
INBI发布了新的文献求助30
32秒前
Catherkk完成签到,获得积分10
32秒前
粱乘风完成签到,获得积分10
32秒前
Belinda完成签到 ,获得积分10
33秒前
AN完成签到,获得积分10
34秒前
myg123完成签到 ,获得积分10
36秒前
Seth完成签到,获得积分10
37秒前
37秒前
神勇友灵完成签到,获得积分10
37秒前
WL完成签到 ,获得积分10
41秒前
43秒前
qcl完成签到,获得积分10
47秒前
49秒前
淡然的熊猫完成签到,获得积分10
49秒前
顺心的安珊完成签到 ,获得积分10
50秒前
51秒前
vsvsgo发布了新的文献求助10
51秒前
负责的白风完成签到,获得积分10
52秒前
shy完成签到,获得积分10
53秒前
life完成签到,获得积分10
54秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022